Femasys Inc. (FEMY) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time FEMY price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 31.4 Near Oversold
Market Cap $143.1M
Volume 23.4K
Fundamentals — 10-Q Q1 2026
Revenue $424,889
Net Income $846,100
EPS $0.00
Gross Margin 62.7%
Operating Margin -994.0%
Net Margin 199.1%
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | Buy | 3,125 | $3.20 | $10,000 | 2026 Aug 7 |
| Sipos Jeremy Alexander | Chief Technology Officer | Buy | 3,125 | $3.20 | $10,000 | 2026 Aug 7 |
| Canning John Charles | Chief Operating Officer | Buy | 4,375 | $3.20 | $14,000 | 2026 Aug 7 |
| Elefant Dov | Chief Financial Officer | Buy | 15,625 | $3.20 | $50,000 | 2026 Aug 7 |
| Lee-sepsick Kathy | Chief Executive Officer | Buy | 15,625 | $3.20 | $50,000 | 2026 Aug 7 |
| Dyett John | Director | Buy | 53,500 | $12.93 | $691,700 | 2021 Jun 23 |
| Larsen Charles | Director | Buy | 7,000 | $13.00 | $91,000 | 2021 Jun 22 |
| Adams John Q JR | Director | Buy | 40,000 | $13.00 | $520,000 | 2021 Jun 22 |
| Uzialko Edward R | Director | Buy | 100,000 | $13.00 | $1.3M | 2021 Jun 22 |
Take FEMY further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put FEMY in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Femasys Inc. next reports.
Set alerts on FEMY
Get notified when Femasys Inc. hits your price targets or technical conditions are met.
Get Started Free